{"id":7385,"date":"2026-09-04T14:03:50","date_gmt":"2026-09-04T14:03:50","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=7385"},"modified":"2026-10-07T15:06:57","modified_gmt":"2026-10-07T15:06:57","slug":"counseling-and-testing-for-infectious-diseases-of-the-clients-of-drug-harm-reduction-organisations-in-bulgaria-trends","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/counseling-and-testing-for-infectious-diseases-of-the-clients-of-drug-harm-reduction-organisations-in-bulgaria-trends\/","title":{"rendered":"Counseling and testing for infectious diseases of the clients of drug harm reduction organisations in Bulgaria (2017 \u2013 2025)"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
Prevalence of psychoactive substance use
Prevalence of medication use
Prevalence of drug use
Drug Prevention<\/a><\/strong><\/td>		Treatment Supply<\/a>
Treatment Demand
Health consequences<\/a>
Harm reduction<\/a><\/strong><\/td>		Drug-related crimes<\/a>
Drug market<\/a>
Drug use and prison<\/a>
Monitoring of publications<\/a>
Attitudes to legal framework changes<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Data base (2004 -2025)<\/a><\/strong><\/p>\n\n\n\n

<\/td>2017<\/strong><\/td>2018<\/strong><\/td>2019<\/strong><\/td>2020<\/strong><\/td>2021<\/strong><\/td>2022<\/strong><\/td>2023<\/strong><\/td>2024<\/strong><\/td>2025<\/strong><\/td><\/tr>
Counseling and testing for HIV<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
Consulted and tested clients<\/td>668<\/td>68<\/td>797<\/td>1335<\/td>222<\/td>30<\/td>290<\/td>926<\/td>2319<\/td><\/tr>
Clients received post-test counseling<\/td>423<\/td>68<\/td>579<\/td>1321<\/td>56<\/td>30<\/td>290<\/td>926<\/td>2319<\/td><\/tr>
Positive results<\/td><\/td>1<\/td>20<\/td>10<\/td>4<\/td>1<\/td>2<\/td>143<\/td>250<\/td><\/tr>
Referred for treatment<\/td>8<\/td>46<\/td>20<\/td>16<\/td>12<\/td>16<\/td>1<\/td>30<\/td>50<\/td><\/tr>
Counseling and testing for Hepatitis B<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
Consulted and tested clients<\/td>144<\/td>36<\/td><\/td><\/td>162<\/td><\/td>10<\/td>926<\/td>2234<\/td><\/tr>
Clients received post-test counseling<\/td>140<\/td>36<\/td><\/td><\/td><\/td><\/td>10<\/td>926<\/td>2234<\/td><\/tr>
Positive results<\/td>13<\/td>1<\/td><\/td><\/td><\/td><\/td><\/td>3<\/td>44<\/td><\/tr>
Referred for treatment<\/td><\/td>49<\/td>11<\/td>32<\/td>37<\/td>31<\/td>19<\/td>32<\/td>33<\/td><\/tr>
Counseling and testing for Hepatitis C<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
Consulted and tested clients<\/td>104<\/td>40<\/td>337<\/td>815<\/td>222<\/td>10<\/td>280<\/td>926<\/td>2234<\/td><\/tr>
Clients received post-test counseling<\/td>103<\/td>38<\/td>337<\/td>802<\/td>56<\/td>10<\/td>280<\/td>926<\/td>2234<\/td><\/tr>
Positive results<\/td>72<\/td>38<\/td>294<\/td>334<\/td>25<\/td>10<\/td>8<\/td>744<\/td>1196<\/td><\/tr>
Referred for treatment<\/td><\/td>49<\/td>11<\/td>32<\/td>37<\/td>31<\/td>19<\/td>32<\/td>33<\/td><\/tr>
Counseling and testing for Syphilis<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
Consulted and tested clients<\/td>127<\/td>40<\/td>195<\/td>469<\/td>222<\/td><\/td>267<\/td>926<\/td>2234<\/td><\/tr>
Clients received post-test counseling<\/td>125<\/td>40<\/td>195<\/td>469<\/td>56<\/td><\/td>267<\/td>926<\/td>2234<\/td><\/tr>
Positive results<\/td>3<\/td><\/td>5<\/td>24<\/td><\/td><\/td>5<\/td>4<\/td>58<\/td><\/tr><\/tbody><\/table>
Source: National Center of Public Health and Analyses<\/sub><\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"

Prevalence of psychoactive substance usePrevalence of medication usePrevalence of drug useDrug Prevention Treatment SupplyTreatment DemandHealth consequencesHarm reduction Drug-related crimesDrug marketDrug use and prisonMonitoring of publicationsAttitudes to legal framework changes Data base (2004 -2025) 2017 2018 2019 2020 2021 2022 2023 2024 2025 Counseling and testing for HIV Consulted and tested clients 668 68 797 1335 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,87],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7385"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=7385"}],"version-history":[{"count":3,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7385\/revisions"}],"predecessor-version":[{"id":8167,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7385\/revisions\/8167"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=7385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=7385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=7385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}